Concomitant acute limb ischemia and myocardial infarction: another challenge of COVID-19's hypercoagulability

Am J Cardiovasc Dis. 2022 Jun 15;12(3):149-152. eCollection 2022.

Abstract

The COVID-19, actual pandemic due to SARS COV 2 is associated with numerous thromboembolic complications. Although venous thrombosis including pulmonary embolisms have been widely described, arterial localization seems rarely reported. Acute limb ischemia and myocardial infarction are two major consequences of arterial thrombosis and their concomitant occurrence among COVID-19 patients is extremely rare. It is an evident aspect of hypercoagulability and a real challenge to physicians. We herein describe the management of a 77 years old COVID-19 patient presenting an acute lower limb ischemia with concomitant myocardial infarction. He underwent coronary angiography with subsequent stent placement then was transferred to the operating room where a thrombectomy was performed. The outcome was poor as the cardiogenic shock persisted in addition to a reperfusion syndrome with multiorgan failure.

Keywords: COVID-19; acute limb ischemia; acute myocardial infarction; hypercoagulability.

Publication types

  • Case Reports